Saturday, May 30, 2015

New Drug Keeps Common Breast Cancer Under Control Longer: Study

Adding Ibrance to standard hormone therapy kept disease from progressing for nine months
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)